These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 23768488)

  • 1. Microbial persistence and the road to drug resistance.
    Cohen NR; Lobritz MA; Collins JJ
    Cell Host Microbe; 2013 Jun; 13(6):632-42. PubMed ID: 23768488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tellurium: A Rare Element with Influence on Prokaryotic and Eukaryotic Biological Systems.
    Vávrová S; Struhárňanská E; Turňa J; Stuchlík S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerant, Growing Cells from Nutrient Shifts Are Not Persister Cells.
    Kim JS; Wood TK
    mBio; 2017 Apr; 8(2):. PubMed ID: 28420737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PerSort Facilitates Characterization and Elimination of Persister Subpopulation in Mycobacteria.
    Srinivas V; Arrieta-Ortiz ML; Kaur A; Peterson EJR; Baliga NS
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33262242
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin: in vitro activity, mechanism of action, and resistance.
    Sanders CC
    Rev Infect Dis; 1988; 10(3):516-27. PubMed ID: 3293157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extreme Antibiotic Persistence via Heterogeneity-Generating Mutations Targeting Translation.
    Khare A; Tavazoie S
    mSystems; 2020 Jan; 5(1):. PubMed ID: 31964772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forming and waking dormant cells: The ppGpp ribosome dimerization persister model.
    Wood TK; Song S
    Biofilm; 2020 Dec; 2():100018. PubMed ID: 33447804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of arsenic compound resistance in prokaryotes and eukaryotes].
    Wysocki R; Bobrowicz P; Ułaszewski S
    Postepy Biochem; 1999; 45(4):304-12. PubMed ID: 10786374
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased susceptibility of transfected prokaryotic and eukaryotic cells to antibiotic selection.
    Asselbergs FA; van Someren P
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1782-4. PubMed ID: 1416866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
    Konaklieva MI; Plotkin BJ
    Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Persisters and Infection: Past, Present, and Progressing.
    Gollan B; Grabe G; Michaux C; Helaine S
    Annu Rev Microbiol; 2019 Sep; 73():359-385. PubMed ID: 31500532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular reprogramming and phenotype switching in
    Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracellular signaling in response to osmotic stress.
    Kültz D; Burg MB
    Contrib Nephrol; 1998; 123():94-109. PubMed ID: 9761963
    [No Abstract]   [Full Text] [Related]  

  • 17. New Strategies to Kill Metabolically-Dormant Cells Directly Bypassing the Need for Active Cellular Processes.
    Stojowska-Swędrzyńska K; Kuczyńska-Wiśnik D; Laskowska E
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans biofilms produce antifungal-tolerant persister cells.
    LaFleur MD; Kumamoto CA; Lewis K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOS response induces persistence to fluoroquinolones in Escherichia coli.
    Dörr T; Lewis K; Vulić M
    PLoS Genet; 2009 Dec; 5(12):e1000760. PubMed ID: 20011100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug persistence - from antibiotics to cancer therapies.
    Kochanowski K; Morinishi L; Altschuler S; Wu L
    Curr Opin Syst Biol; 2018 Aug; 10():1-8. PubMed ID: 30740553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.